GenePOC Inc:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:GenePOC Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C12150
◆発行会社(調査会社):GlobalData
◆発行日:2018年12月
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
GenePOC Inc (GenePOC), a subsidiary of Debiopharm Group, is a medical device company that develops rapid molecular devices for providing targeted therapy. The company offers on-the-spot diagnostic devices for achieving optimal patient management. It offers diagnostic instruments based on a novel centripetal technology platform. GenePOC also provides automated point-of-care molecular diagnostic system that facilitates early detection and the prevention of infectious diseases. The company’s POC diagnostic system is employed in the detection of respiratory tract infections, neonatal infections, gastrointestinal tract, and others. GenePOC is headquartered in Quebec City, Quebec, Canada.

GenePOC Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
GenePOC Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
GenePOC Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
GenePOC Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
GenePOC Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
GenePOC Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
GenePOC Inc, Medical Equipment, Deal Details 10
Venture Financing 10
GenePOC Raises Funds through Venture Financing 10
Partnerships 11
GenePOC Enters into Distribution Agreement With Cardinal Health 11
Equity Offering 12
Debiopharm Invests in GenePOC 12
Acquisition 13
Debiopharm Acquires Majority Stake in GenePOC from Emerillon Capital 13
GenePOC Inc – Key Competitors 14
GenePOC Inc – Key Employees 15
GenePOC Inc – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Recent Developments 17
Other Significant Developments 17
Mar 22, 2018: Novacyt Signs Assay Development Contract for Diagnosis of Respiratory Infections with GenePOC 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
GenePOC Inc, Medical Equipment, Key Facts 2
GenePOC Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
GenePOC Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
GenePOC Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
GenePOC Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
GenePOC Inc, Deals By Market, 2012 to YTD 2018 8
GenePOC Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
GenePOC Raises Funds through Venture Financing 10
GenePOC Enters into Distribution Agreement With Cardinal Health 11
Debiopharm Invests in GenePOC 12
Debiopharm Acquires Majority Stake in GenePOC from Emerillon Capital 13
GenePOC Inc, Key Competitors 14
GenePOC Inc, Key Employees 15
GenePOC Inc, Other Locations 16

List of Figures
GenePOC Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
GenePOC Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
GenePOC Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
GenePOC Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
GenePOC Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
GenePOC Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
GenePOC Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
GenePOC Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[GenePOC Inc:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Adtran Inc (ADTN):企業の財務・戦略的SWOT分析
    Adtran Inc (ADTN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Xtant Medical Holdings Inc (XTNT):企業の財務・戦略的SWOT分析
    Summary Xtant Medical Holdings Inc (Xtant Medical), formerly Bacterin International Holdings Inc, is a medical device company that develops regenerative medicine products and medical devices. The company’s products include 3Demin, osteosponge, osteosponge SC, osteoselect DBM Putty, OsteoSTX, osteowr …
  • Frigo Pak Gida Maddeleri Sanayi ve Tic.:企業の戦略・SWOT・財務分析
    Frigo Pak Gida Maddeleri Sanayi ve Tic. - Strategy, SWOT and Corporate Finance Report Summary Frigo Pak Gida Maddeleri Sanayi ve Tic. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • Haplogen GmbH:製薬・医療:M&Aディール及び事業提携情報
    Summary Haplogen GmbH (Haplogen) is a biopharmaceutical company that improves human health by fighting against infectious diseases such as common cold, dengue fever, influenza and hepatitis C. The company utilizes its proprietary genetics technology platform to identify novel pathogen host factors a …
  • Busan Bank Co., Ltd.:企業の戦略・SWOT・財務情報
    Busan Bank Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Busan Bank Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Quadra – Power Generation:発電所・企業SWOT分析
    Quadra - Power Generation - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key emp …
  • Chevron Nigeria Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary Chevron Nigeria Ltd (Chevron Nigeria) a subsidiary of Chevron Corporation is an oil and gas company that offers exploration, production and transportation of crude oil and natural gas. The company distributes products such as additives, jet fuels, base oil, chemical, fuel, lubricant, marine …
  • Teachers Insurance and Annuity Association of America (TIAA):企業の戦略・SWOT・財務情報
    Teachers Insurance and Annuity Association of America (TIAA) - Strategy, SWOT and Corporate Finance Report Summary Teachers Insurance and Annuity Association of America (TIAA) - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers …
  • Riemser Pharma GmbH:製薬・医療:M&Aディール及び事業提携情報
    Summary Riemser Pharma GmbH (Riemser), formerly Riemser Arzneimittel AG is a distributor of lifecycle management products. The company offers analgesics products, cardiovascular products, over-the-counter medicines, prescription drugs and dental products. It provides medical products for the treatme …
  • Regis Corporation (RGS):企業の財務・戦略的SWOT分析
    Regis Corporation (RGS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Procurri Corporation Limited (BVQ):企業の財務・戦略的SWOT分析
    Procurri Corporation Limited (BVQ) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Princeton University:製薬・医療:M&Aディール及び事業提携情報
    Summary Princeton University (Princeton) is an education service provider that offers undergraduate and graduate instruction. The university offer education in the areas of humanities, social sciences, natural sciences and engineering. It offers services such as health services, event planning, exte …
  • Inova Health System:医療機器:M&Aディール及び事業提携情報
    Summary Inova Health System (Inova) is a non-profit health care delivery system. It owns owns, operates and manages several research, educational, clinical and hospital facilities. It offers home health and long term care services, joint replacement services, liver disease services, mental health se …
  • GS Yuasa Corporation (6674):企業の財務・戦略的SWOT分析
    GS Yuasa Corporation (6674) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • ARxIUM-医療機器分野:企業M&A・提携分析
    Summary ARxIUM, formerly Intelligent Hospital Systems Inc, a subsidiary of Van Humbeck Family, is a medical device company that designs and manufactures automated solutions for the hospital pharmacy. The company’s products include RxWorks pro, workflow, inventory management, IV compounding system, h …
  • Hubbell Inc (HUBB):企業の財務・戦略的SWOT分析
    Hubbell Inc (HUBB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Huatai Securities Co., Ltd. (601688):企業の財務・戦略的SWOT分析
    Huatai Securities Co., Ltd. (601688) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Pirelli & C. S.p.A.:戦略・SWOT・企業財務分析
    Pirelli & C. S.p.A. - Strategy, SWOT and Corporate Finance Report Summary Pirelli & C. S.p.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Cellmid Ltd (CDY):医療機器:M&Aディール及び事業提携情報
    Summary Cellmid Ltd (Cellmid), formerly Medical Therapies Ltd, is a life sciences company that develops and commercializes diagnostic and therapeutic products. The company holds comprehensive portfolio of intellectual property relating to the novel targets midkine and FGF5. It offers products such a …
  • Mitsui & Co Ltd (8031):電力:M&Aディール及び事業提携情報
    Summary Mitsui & Co Ltd (Mitsui) is a business conglomerate. The company sells, distributes, purchases, markets and supplies wide variety of products in business areas including iron and steel; non-ferrous metals; machinery; electronics; chemicals; energy-related commodities; foods & retail, lifesty …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆